Safety of low-dose low-molecular-weight-heparins in thrombocytopenic stem cell transplantation patients : a case series and review of the literature
Few attempts have been made to examine the feasibility of safely administering low-molecular-weight-heparins (LMWHs) in the presence of concurrent thrombocytopenia. We retrospectively investigated the safety of low-dose LMWH in BMT patients, a population at risk of bleeding. In total, 26 patients re...
Gespeichert in:
Veröffentlicht in: | Bone marrow transplantation (Basingstoke) 2005-06, Vol.35 (11), p.1071-1077 |
---|---|
Hauptverfasser: | , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | Few attempts have been made to examine the feasibility of safely administering low-molecular-weight-heparins (LMWHs) in the presence of concurrent thrombocytopenia. We retrospectively investigated the safety of low-dose LMWH in BMT patients, a population at risk of bleeding. In total, 26 patients received at least one dose of low-dose enoxaparin (ie |
---|---|
ISSN: | 0268-3369 1476-5365 |
DOI: | 10.1038/sj.bmt.1704952 |